Overview
- Editors:
-
-
Yoshikuni Mizuno
-
Department of Neurology, Juntendo University School of Medicine, Hongo, Bunkyo, Tokyo 113, Japan
-
Donald B. Calne
-
Neurodegenerative Disorders Center, The University of British Columbia, Vancouver, Canada
Health Sciences Center, The Vancouver Hospital, Vancouver, Canada
-
R. Horowski
-
Clinical Research, Special Research Projects, Schering AG Berlin, Berlin 65, Germany
Access this book
Other ways to access
Table of contents (21 chapters)
-
Front Matter
Pages i-xiii
-
Genetic, Growth, and Environmental Factors
-
-
-
- Patrick L. McGeer, Edith G. McGeer
Pages 19-27
-
-
-
-
Metals and, Free Radicals
-
-
- C. W. Olanow, D. B. Calne, N. S. Chu, D. P. Perl
Pages 53-62
-
- Moussa B. H. Youdim, Dorit Ben-Shachar, Peter Riederer
Pages 63-78
-
-
- Sten Orrenius, Pierluigi Nicotera
Pages 93-103
-
- Peter Riederer, Moussa B. H. Youdim
Pages 105-108
-
Energy Metabolism and Neurotoxins
-
Front Matter
Pages 109-109
-
-
- Lechoslaw Turski, Chrysanthy Ikonomidou
Pages 127-140
-
- Robert Siman, Mary J. Savage, Jill M. Roberts-Lewis
Pages 141-148
-
- Toshiharu Nagatsu, Makoto Naoi, Toshimitsu Niwa, Mitsuo Yoshida
Pages 149-159
-
-
Special Topics in Neurodegeneration
-
Front Matter
Pages 167-167
About this book
In 1991, a small annual meeting named "International Winter Conference on Neurodegeneration (lWCN)" was established; the aim of this meeting is to review the neurodegenerative disorders and to attempt to explore how progress might be made in this field, as the neurodegenerative disorders have been emerging to be one of the major causes of morbidity and mortality in modern societies. The first meeting took place in Seefeld, Austria, in February 1992; the topics for the first IWCN were chosen to provide a broad foundation of clinical science, which included the problem of aging, classification of neurodegenerative disorders and of Alzheimer's dis natural history, pathology, and clinical neurology ease, Parkinson's disease, and amyotrophic lateral sclerosis. The fundamental pathology underlying these neurodegenerative disorders is neuronal cell death. For the understanding of pathophysiol ogy and the development of neuroprotective treatment for these dis orders, elucidation of the mechanism of neuronal cell death at the cellular and molecular level is essential. With this concept in mind, the second IWCN was held in Whistler Village in Canada in January 1993. Funding was generously provided by Schering AG, Berlin, and for the excellent organization we have to thank Ms. Ingeborg Runge.
Editors and Affiliations
-
Department of Neurology, Juntendo University School of Medicine, Hongo, Bunkyo, Tokyo 113, Japan
Yoshikuni Mizuno
-
Neurodegenerative Disorders Center, The University of British Columbia, Vancouver, Canada
Donald B. Calne
-
Health Sciences Center, The Vancouver Hospital, Vancouver, Canada
Donald B. Calne
-
Clinical Research, Special Research Projects, Schering AG Berlin, Berlin 65, Germany
R. Horowski
